RxDoctor Payments Data

Subha Clarke

Internal Medicine · Wilbraham, MANPI 1477572436

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $1,823 of the $2,501 with a category attached, or 72.9%. Eli Lilly accounts for 98.1% of it on its own, with 1 other manufacturer making up the rest. Reporting peaked in 2019 at $1,414 and has fallen 96.7% since, to $47 in 2022. Among internal medicine clinicians in MA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,501in general payments, 2019–2025

Across 49 payments — averaging $51.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eli Lilly$2K
  • Xeris Pharmaceuticals, Inc.$47
$1,286,572in research payments, 2019–2025

Across 155 payments — averaging $8300.46 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$457K
  • Eli Lilly$401K
  • Modernatx, Inc.$213K
  • Akebia Therapeutics Inc$73K
  • AbbVie$60K
  • Kowa Research Institute, Inc.$49K
  • plus $34K from 7 others

What the payments were for

  • Travel & lodging$1,82373%
  • Food & beverage$67827%

General payments by program year

19
20
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Eli Lilly47$2,454
Xeris Pharmaceuticals, Inc.2$47

How this compares

$2,501 in reported general payments places this provider in the 90th percentile of 4,983 internal medicine providers in Massachusetts.

See all internal medicine providers in Massachusetts

Other internal medicine in Wilbraham

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →